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Introduction: The majority of cases of both lung cancer and chronic 
obstructive pulmonary disease (COPD) are attributable to cigarette 
smoking, but whether COPD is an independent risk factor for lung 
cancer remains unclear.
Methods: We used The Health Improvement Network, a U.K. general 
practice database, to identify incident cases of lung cancer and controls 
matched on age, sex, and practice. Using conditional logistic regression, 
we assessed the effects of timing of first diagnoses of COPD, pneumo-
nia, and asthma on the odds of lung cancer, adjusting for smoking habit.
Results: Of 11,888 incident cases of lung cancer, 23% had a prior 
diagnosis of COPD compared with only 6% of the 37,605 controls. 
The odds of lung cancer in patients who had COPD diagnosed 
within 6 months of their cancer diagnosis were 11-fold those of 
patients without COPD (odds ratio 11.47, 95% confidence interval 
9.38–14.02). However, when restricted to earlier COPD diagnoses, 
with adjustment for smoking, the effect markedly diminished (for 
COPD diagnoses >10 years before lung cancer diagnosis, odds ratio: 
2.18, 95% confidence interval: 1.87–2.54). The pattern was similar 
for pneumonia. The effect of COPD on lung cancer remained after 
excluding patients who had a codiagnosis of asthma.
Conclusion: A diagnosis of COPD is strongly associated with a diag-
nosis of lung cancer, however, this association is largely explained by 
smoking habit, strongly dependent on the timing of COPD diagnosis, 
and not specific to COPD. It seems unlikely, therefore, that COPD is 
an independent risk factor for lung cancer.
Key Words: Lung neoplasms, Pulmonary disease, Chronic obstruc-
tive, Risk factors, Cigarette smoking.
(J Thorac Oncol. 2013;8: 6–11)
Chronic obstructive pulmonary disease (COPD) and lung cancer are two of the most important smoking-related 
diseases worldwide, with a huge combined mortality bur-
den.1,2 Many consider the presence of COPD itself to be an 
independent risk factor for lung cancer above and beyond its 
association with smoking,3,4 but others argue that they are just 
manifestations of the same exposure.
Brenner et al.3 recently published a meta-analysis of 
the relationship between lung cancer and prior lung diseases. 
In the 39 studies assessing COPD, authors made efforts to 
adjust for smoking and did so to varying degrees. The major-
ity reported that COPD was associated with an increase in 
risk of lung cancer, the highest reported increase being nine-
fold,4 although a few, including one study in never smokers,5 
showed reduced risks. The combined relative risk of lung can-
cer in people with a diagnosis of COPD, chronic bronchitis or 
emphysema, compared with people without these diagnoses, 
was 1.83 (95% confidence interval [CI] 1.6–2.11) but authors 
reported significant statistical heterogeneity across studies, 
particularly in the types of controls used and in diagnos-
tic methods.3 Contributing studies were generally small and 
varied considerably in their methodologies (often relying on 
retrospective self-reported data on smoking) and definitions 
of COPD. Populations were often neither random nor popu-
lation-based as several included patients already selected as 
high risk for lung cancer screening trials.6,7
When patients with lung cancer first present to a clini-
cian, their symptoms may be consistent with a new diagnosis 
of COPD and are recorded as such, before the lung cancer 
diagnosis is made. Patients referred to secondary care for sus-
pected lung cancer may consequently be investigated for, and 
diagnosed with, COPD. For this reason, in studies of COPD 
and lung cancer, there is likely to be strong ascertainment 
bias. Brenner et al.3 were not able to account for this in their 
meta-analysis as many studies did not have data on when the 
diagnoses were made.
We undertook a large case-control study using 
prospectively collected general practice (GP) data, which 
allowed us to quantify the association between COPD and lung 
cancer in the U.K. population while controlling for smoking and 
the impact of timing of diagnoses. To assess the specificity of any 
association between COPD and lung cancer, we also considered 
other common lung diseases (asthma and pneumonia).
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PATIENTS AND METHODS
Study Population
We conducted a matched case-control study using The 
Health Improvement Network (THIN) database. This is a lon-
gitudinal, U.K. primary care medical research database, which 
currently has data on over 8.2 million patients. This is likely 
to be a representative sample of the U.K. general population 
of whom 99% are registered with a general practice (GP). 
Medical diagnoses, symptoms, investigations, results, and 
prescriptions are entered into a computer system, both dur-
ing consultations within GP and after communication from 
secondary care.
Our cases were patients who had a diagnosis of lung 
cancer (identified using Read medical codes) first recorded 
between January 2000 and July 2009 and at least 12 months 
of prospectively computerized data before their lung cancer 
diagnosis date. Controls were randomly selected from the gen-
eral population in THIN and up to four controls were matched 
to each case on sex, year of birth, and the GP with which they 
were registered. Controls had no evidence of lung cancer in 
at least 12 months of data before their index date (which was 
defined as the date of lung cancer diagnosis in their matched 
case).
Definition of Exposures
Read codes for COPD, asthma, and pneumonia were 
used to identify patients with these diagnoses before the lung 
cancer diagnosis or index date. We grouped dates of first diag-
nosis into diagnostic latency categories such as those made 
within 6 months, between 6 months and 1 year, between 1 year 
and 5 years, between 5 years and 10 years, and 10 years or 
more, before the lung cancer diagnosis or index date.
Covariate Definitions
We defined smoking habit as never, current, or ex, and 
smoking quantity as light (1–9 cigarettes per day), moderate 
(10–19 cigarettes per day), or heavy (≥20 cigarettes per day) 
using Read coding or, where available, the record of num-
ber of cigarettes smoked daily. Where there was more than 
one smoking record, we used the highest smoking quantity 
recorded before the lung cancer or index date as being most 
representative of lifetime smoking quantity (unmodified by a 
diagnosis of lung cancer). We used Townsend score, a mea-
sure of area-level socioeconomic deprivation, divided into 
quintiles to assess the effect of socioeconomic status.
Statistical Methods
Statistical analyses were performed using Stata MP ver-
sion 12 (StataCorp, College Station, TX). We used conditional 
logistic regression to estimate odds ratios (OR) of lung cancer 
associated with a prior diagnosis of COPD, asthma, and pneu-
monia, according to the timing of diagnoses, and explored any 
changes in effect after adjusting for smoking and Townsend 
quintile. To account for any diagnostic uncertainty between 
asthma and COPD, we identified patients who had records of 
both and repeated analyses in those exclusively with COPD 
or asthma.
RESULTS
We matched 11,947 cases of lung cancer with 37,774 
controls. Fifty-nine cases (and their 169 matched controls) 
with an age of less than 40 years at diagnosis were excluded, 
leaving 11,888 cases and 37,605 controls in the final analy-
sis. Patients had a median of 9.6 years (interquartile range 
5.7–13.5 years) of prospectively recorded GP data before their 
index date; the cases had a median of 9.5 years and controls 
of 9.4 years.
Fifty-nine percent of cases were men and the majority 
(59%) were more than 70 years old at diagnosis. Cases had 
greater socioeconomic deprivation than controls, with 19% of 
cases being in the highest Townsend quintile compared with 
14% of controls (Table 1).
People with cancer were more likely to smoke (90% 
of cases compared with 61% of controls had ever smoked), 
and were more likely to have smoked heavily (38% and 13%, 
respectively). Cases were nearly four times as likely to have 
had a prior diagnosis of COPD overall (23% compared with 
6% of controls) and across all diagnostic latency categories 
with the most marked difference in the 6 months before lung 
cancer diagnosis (3.4% compared with 0.4% of controls). The 
prevalence of asthma and pneumonia was also higher in cases 
than in controls and displayed a similar pattern of marked dif-
ferences closer to the time of lung cancer diagnosis (Table 1).
Smoking was strongly associated with lung cancer 
with odds in the heaviest smokers more than 15 times those 
in never smokers OR: 15.58, 95% confidence interval: ([CI] 
14.35–16.91). The association between socioeconomic sta-
tus (Townsend quintile) and lung cancer was confounded by 
smoking but adjusted ORs remained significantly increased 
in the most deprived group compared with the least deprived 
(OR: 1.58, 95% CI: 1.44–1.73) (Table 2).
COPD diagnoses, made within 6 months of the index 
date, were associated with an 11-fold increase in the odds of 
lung cancer compared with no prior COPD diagnosis, how-
ever, this was heavily confounded by smoking, and the OR 
was 6.81 (95% CI 5.49–8.45), after adjusting for smoking and 
socioeconomic status. The timing of diagnosis also had a con-
siderable effect, with the adjusted OR falling to 2.18 (95% CI 
1.87–2.54), when diagnoses made within 10 years of the lung 
cancer or index date were excluded.
A previous diagnosis of pneumonia was associated 
with increased odds of lung cancer with the pattern regarding 
diagnostic timing similar to that seen in COPD (Table 2). 
There was a very strong association with diagnoses of 
pneumonia made within 6 months of index date (OR: 14.91, 
95% CI: 11.75–18.94) and there was evidence of confounding 
by smoking but to a lesser degree than in COPD (adjusted OR 
for diagnoses within 6 months: 13.33, 95% CI: 10.24–17.35). 
There remained an association when we excluded diagnoses 
of pneumonia made within 10 years of lung cancer or index 
date (adjusted OR: 1.46, 95% CI: 1.15–1.86). The strength of 
association between a diagnosis of asthma and lung cancer 
was less than that of COPD or pneumonia, but there was still 
evidence of confounding by smoking and an effect of timing 
of diagnosis. After adjusting for smoking and socioeconomic 
status and excluding diagnoses made within 10 years of lung 
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cancer diagnosis, odds of lung cancer were 1.19 (95% CI: 
1.06–1.33) times those in people without asthma.
Of patients with a prior COPD diagnosis, 40% (60% of 
cases and 33% of controls) also had a diagnosis of asthma, 
showing considerable diagnostic overlap. The effect of COPD 
on lung cancer remained after excluding the patients who 
also had asthma, with similar ORs to those shown in Table 2 
across all diagnostic time windows (within 6 months adjusted 
OR: 7.89, 95% CI: 6.03–10.34, >10 years adjusted OR: 2.23, 
95% CI: 1.74–2.87). However, when we assessed the effect of 
asthma on lung cancer risk, excluding people who also had 
a diagnosis of COPD, we found no independent association 
except in the most proximal diagnoses (data not shown).
DISCUSSION
We found evidence of a strong association between 
COPD and lung cancer, but this was largely explained by the 
effect of smoking and is most apparent in recently diagnosed 
cases of COPD, suggesting a strong element of ascertainment 
bias. Our findings also suggest that this association is not 
specific to COPD; the relationship between pneumonia 
and lung cancer followed a very similar pattern, with a 
TABLE 1.  Description of Cases and Controls
Cases (n=11,888) Controls (n=37,605)
n % n %
Sex (matched) Female 4863 40.9 15,639 41.6
Male 7025 59.1 21,966 58.4
Age at diagnosis 40–49 315 2.6 1056 2.8
(years, matched) 50–59 1366 11.5 4732 12.6
60–69 3229 27.2 10,946 29.1
70–79 4501 37.9 14,499 38.6
≥80 2477 20.8 6372 16.9
Townsend quintile 1 (Least deprived) 2037 17.1 8735 23.2
2 2200 18.5 8187 21.8
3 2380 20.0 7420 19.7
4 2609 21.9 6742 17.9
5 (Most deprived) 2196 18.5 5064 13.5
Missing 466 3.9 1457 3.9
Smoking Never 1176 9.9 14,527 38.6
Highest ever Light 1010 8.5 2,409 6.4
recorded before Moderate 2433 20.5 3788 10.1
index date Heavy 4516 38.0 4829 12.8
Smoker but unknown quantity 2236 18.8 8710 23.2
 Missing smoking status 517 4.3 3342 8.9
COPD No diagnosis before index date 9131 76.8 35,319 93.9
Interval between Within 6 months 404 3.4 140 0.4
first diagnosis and 6 –12 mo 199 1.7 172 0.5
index date 1–5 yr 1033 8.7 947 2.5
5–10 yr 690 5.8 580 1.5
 ≥10 yr 431 3.6 447 1.2
Asthma No diagnosis before index date 9893 83.2 33,640 89.5
Interval between within 6 months 111 0.9 108 0.3
first diagnosis and 6–12 mo 71 0.6 130 0.3
index date 1–5 yr 616 5.2 1093 2.9
5–10 yr 620 5.2 1188 3.2
 ≥10 yr 577 4.9 1446 3.8
Pneumonia No diagnosis before index date 10,819 91.0 36,540 97.2
Interval between within 6 months 378 3.2 88 0.2
first diagnosis and 6–12 mo 74 0.6 79 0.2
index date 1–5 yr 318 2.7 422 1.1
5–10 yr 164 1.4 220 0.6
 ≥10 yr 135 1.1 256 0.7
COPD, chronic obstructive pulmonary disease.
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strong association for proximal diagnoses and considerable 
confounding by smoking. The effect of timing of diagnosis 
of asthma was similar to that observed with COPD and 
pneumonia, however, after accounting for smoking, diagnostic 
overlap, and ascertainment bias we found no association 
between asthma and lung cancer.
Strengths and Weaknesses
We studied a large nationally representative population 
with a median of almost 10 years of prospectively recorded 
GP data. We have previously shown lung cancer incidence in 
THIN to be representative of the U.K. lung cancer popula-
tion through comparison with data from the National Cancer 
Registry.8 Records of COPD in U.K. primary care data have 
not been validated to date; however, previous work has shown 
that demographics and smoking habits of patients with COPD 
in THIN are consistent with those in the U.K. population 
confirmed as having the disease.9 In addition, all diagnoses 
made in secondary care in the United Kingdom are communi-
cated to the patient’s GP and there are financial incentives for 
GPs to ensure that these diagnoses are recorded.
We have extensively validated the smoking data in 
THIN and found them to be similar to standard procedure 
national survey measures.10 It remains likely that there is some 
error and inaccuracy in the recorded data on smoking, and 
particularly passive smoking, but this limitation applies to all 
studies on this subject as they rely on the accuracy of reports 
by participants. We believe that the quality and completeness 
of our data, which were prospectively recorded before the 
diagnosis of lung cancer, will be better than those that have 
relied on retrospective reporting.5,11,12 Adequate adjustment 
for smoking is crucial, given the strength of association 
between lung cancer and smoking, and we suspect that most 
of the remaining association seen after excluding COPD 
TABLE 2.  Odds Ratios for Lung Cancer (N=49,493; 11,888 Cases and 37,605 Controls)
  OR 95% CI Adjusted ORa 95% CI
Townsend quintile 1 (Least deprived) 1.00 1.00
2 1.19 1.11–1.28 1.15 1.06–1.24
3 1.48 1.38–1.59 1.28 1.18–1.38
4 1.88 1.75–2.03 1.43 1.32–1.55
5 (Most deprived) 2.26 2.08–2.44 1.58 1.44–1.73
 Missing 1.65 1.41–1.94 1.20 1.00–1.43
Smoking Never 1.00 1.00
Highest ever recorded Light 6.00 5.42–6.65 5.88 5.31–6.52
before index date Moderate 9.67 8.87–10.54 9.33 8.56–10.18
Heavy 15.58 14.35–16.91 14.88 13.71–16.16
Smoker but unknown quantity 3.48 3.20–3.78 3.44 3.17–3.74
 Missing smoking status 1.79 1.59–2.02 1.76 1.56–1.99
COPD No diagnosis before index date 1.00 1.00
Interval between within 6 mo 11.47 9.38–14.02 6.81 5.49–8.45
first diagnosis and 6–12 mo 4.76 3.85–5.89 2.52 2.00–3.19
index date 1–5 yr 4.34 3.95–4.78 2.48 2.24–2.75
5–10 yr 4.83 4.29–5.44 2.68 2.36–3.05
 ≥10 yr 3.74 3.25–4.31 2.18 1.87–2.54
Asthma No diagnosis before index date 1.00 1.00
Interval between within 6 months 3.63 2.77–4.76 2.92 2.15–3.97
first diagnosis and 6–12 mo 1.94 1.44–2.60 1.51 1.08–2.12
index date 1–5 yr 1.91 1.72–2.12 1.34 1.20–1.51
5–10 yr 1.83 1.65–2.03 1.43 1.27–1.60
 ≥10 yr 1.33 1.20–1.47 1.19 1.06–1.33
Pneumonia No diagnosis before index date 1.00 1.00
Interval between within 6 mo 14.91 11.75–18.94 13.33 10.24–17.35
first diagnosis and 6–12 mo 3.37 2.42–4.70 2.89 1.99–4.18
index date 1–5 yr 2.59 2.22–3.02 2.16 1.82–2.57
5–10 yr 2.52 2.04–3.10 2.11 1.66–2.67
 ≥10 yr 1.68 1.35–2.09 1.46 1.15–1.86
aAdjusted for smoking and Townsend quintile—odds ratios by smoking quantity are adjusted for Townsend quintile and those by Townsend quintile are adjusted for smoking 
quantity.
OR, odds ratio; CI, confidence interval; COPD, chronic obstructive pulmonary disease.
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diagnoses made within 6 months of lung cancer diagnosis can 
be attributed to smoking. Residual confounding by smoking 
could also explain the graded increase in risk of lung cancer 
with each level of socioeconomic deprivation in our study and 
in previous research.13,14
The presence of ascertainment bias in studies of COPD 
and lung cancer may lead to overestimates in the size of asso-
ciation. People with symptoms of lung cancer are likely to 
undergo more investigations and clinical assessment than 
those without, and this may result in a diagnosis of COPD 
being made in the few weeks or months before the diagnosis 
of lung cancer. By studying the timing of COPD diagnosis in 
relation to lung cancer, we were able to demonstrate just how 
important it is. In addition, people with any chronic lung dis-
ease, particularly COPD, will be monitored with more regular 
contact and investigations by health professionals, providing 
greater opportunity for a subsequent diagnosis of lung cancer. 
This, combined with residual confounding by smoking could 
fully explain the remaining association seen with diagnoses of 
COPD made more than 6 months before lung cancer.
To determine whether the pattern of association between 
COPD and lung cancer was specific to COPD, we also assessed 
the effect of other lung diseases and found that diagnoses of 
pneumonia followed a very similar pattern. The association 
with proximal diagnoses of pneumonia may reflect an ele-
ment of reverse causality, in addition to ascertainment bias, as 
tumors may cause bronchial obstruction or immunosuppres-
sion, making patients more susceptible to infection.
It would be interesting to assess the relationship 
between COPD and lung cancer according to COPD severity, 
lung cancer stage, and histological subtype. Unfortunately, the 
majority of patients do not have this information electroni-
cally coded in THIN. There are some lung function data in the 
database, however, these are largely incomplete and when we 
attempted to assess the effect of severity on odds of develop-
ing lung cancer, we were only able to calculate percentage of 
predicted forced expiratory volume in 1 second for 40% of the 
patients with COPD. The further division of this, according 
to diagnostic latency categories, resulted in small numbers, 
which we felt could not produce reliable results.
Comparison with Other Studies
In an attempt to address the problem of adequate adjust-
ment for smoking, Turner et al.15 studied 448,600 individuals 
who reported to be never smokers in the baseline survey of the 
United States Cancer Prevention Study II. Over the 20-year 
follow-up period, lung cancer mortality was not associated 
with self-reported chronic bronchitis, but was with emphy-
sema (hazard ratio [HR]: 1.66, 95% CI: 1.06–2.59) and with 
combined emphysema and chronic bronchitis (HR: 2.44, 95% 
CI: 1.22–4.9). Of the 1759 who died from lung cancer, only 
48, 20, and eight people reported diagnoses of chronic bron-
chitis, emphysema, or both, respectively. Although the authors 
attempted to account for the effects of passive smoking, we 
would argue that if these people really did have emphysema, 
it is highly likely that this was caused by exposure to cigarette 
smoke and either represents misreported personal smoking 
history or passive smoking. A more recent study did not detect 
an association between obstructive lung disease and mortality 
caused by lung cancer in female never smokers (HR: 0.97, p = 
0.909) although the number of exposed cases in this subgroup 
was also small.16
Many previous studies of COPD and lung cancer do not 
assess the effect of timing of diagnoses and those that do have 
small numbers.5,11 The authors of a Chinese study, for exam-
ple, reported ORs for lung cancer of 2.9 (95% CI: 2.0–4.1) 
and 1.9 (1.2–3.1) in people diagnosed with COPD 1 to 5 and 
6 to 10 years before lung cancer diagnoses (compared with 
those who did not have a diagnosis of COPD at 1 year before 
lung cancer diagnosis), but there were only 74 and 32 cases 
in each of these groups.11 In the study by Turner et al.15 of 
never smokers, they found that the strength of the association 
between emphysema and lung cancer actually increased when 
they excluded early years of follow-up; however, as reported 
above, their overall number of exposed cases was very small.
It could be argued that diagnoses of COPD based on 
lung function tests or radiological imaging are more accu-
rate than GP diagnoses. Three previous studies investigated 
the association between radiographic evidence of emphysema 
and risk of lung cancer; two found an increase in risk,6,7 but 
the other found no significant effect.17 Studies that focused 
on presence and degree of airflow obstruction predominantly 
found it to be associated with increased risk of lung can-
cer.7,17,18 Although these are cohort studies, all relied on partic-
ipant-reported smoking history, collected only on entry to the 
study, and thus, may have been unable to adequately adjust for 
this important confounder.
Clinical Relevance
Our data suggest that the association between COPD and 
lung cancer is largely because of confounding by smoking and 
ascertainment bias, and do not support COPD as an indepen-
dent risk factor for lung cancer. There is, however, an extremely 
strong unadjusted relationship between both COPD and pneu-
monia and lung cancer in the 6 months immediately before lung 
cancer diagnosis. This is useful in a clinical context, highlight-
ing the need to consider a diagnosis of lung cancer when making 
new diagnoses of COPD or pneumonia, and supporting the cur-
rent recommendations of the American Thoracic Society19 and 
the U.K. National Institute for Health and Clinical Excellence,20 
that all patients should have a chest radiograph looking for evi-
dence of lung cancer at the time of COPD diagnosis.
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